BACKGROUND: Only a few long term smokers develop symptomatic chronic obstructive pulmonary disease (COPD) and this may be due, at least in part, to genetic susceptibility to the disease. Transforming growth factor beta1 (TGF-beta1) has a number of actions that make it a candidate for a role in the pathogenesis of COPD. We have investigated a single nucleotide polymorphism at exon 1 nucleotide position 29 (T-->C) of the TGF-beta1 gene that produces a substitution at codon 10 (Leu-->Pro). METHODS: The frequency of this polymorphism was determined in 165 subjects with COPD, 140 healthy blood donors, and 76 smokers with normal lung function (resistant smokers) using the polymerase chain reaction and restriction enzyme fragment length polymorphism. RESULTS: The distribution of genotypes was Leu-Leu (41.8%), Leu-Pro (50.3%), and Pro-Pro (7.9%) for subjects with COPD, which was significantly different from the control subjects (blood donors: Leu-Leu (29.3%), Leu-Pro (52.1%) and Pro-Pro (18.6%), p=0.006; resistant smokers: Leu-Leu (28.9%), Leu-Pro (51.3%) and Pro-Pro (19.7%), p=0.02). The Pro10 allele was less common in subjects with COPD (33%) than in blood donors (45%; OR=0.62, 95% CI 0.45 to 0.86, p=0.005) and resistant smokers (45%; OR=0.59, 95% CI 0.40 to 0.88, p=0.01). CONCLUSIONS: The proline allele at codon 10 of the TGF-beta1 gene occurs more commonly in control subjects than in individuals with COPD. This allele is associated with increased production of TGF-beta1 which raises the possibility that TGF-beta1 has a protective role in COPD.
BACKGROUND: Only a few long term smokers develop symptomatic chronic obstructive pulmonary disease (COPD) and this may be due, at least in part, to genetic susceptibility to the disease. Transforming growth factor beta1 (TGF-beta1) has a number of actions that make it a candidate for a role in the pathogenesis of COPD. We have investigated a single nucleotide polymorphism at exon 1 nucleotide position 29 (T-->C) of the TGF-beta1 gene that produces a substitution at codon 10 (Leu-->Pro). METHODS: The frequency of this polymorphism was determined in 165 subjects with COPD, 140 healthy blood donors, and 76 smokers with normal lung function (resistant smokers) using the polymerase chain reaction and restriction enzyme fragment length polymorphism. RESULTS: The distribution of genotypes was Leu-Leu (41.8%), Leu-Pro (50.3%), and Pro-Pro (7.9%) for subjects with COPD, which was significantly different from the control subjects (blood donors: Leu-Leu (29.3%), Leu-Pro (52.1%) and Pro-Pro (18.6%), p=0.006; resistant smokers: Leu-Leu (28.9%), Leu-Pro (51.3%) and Pro-Pro (19.7%), p=0.02). The Pro10 allele was less common in subjects with COPD (33%) than in blood donors (45%; OR=0.62, 95% CI 0.45 to 0.86, p=0.005) and resistant smokers (45%; OR=0.59, 95% CI 0.40 to 0.88, p=0.01). CONCLUSIONS: The proline allele at codon 10 of the TGF-beta1 gene occurs more commonly in control subjects than in individuals with COPD. This allele is associated with increased production of TGF-beta1 which raises the possibility that TGF-beta1 has a protective role in COPD.
Authors: M A Rivera; M Echegaray; T Rankinen; L Pérusse; T Rice; J Gagnon; A S Leon; J S Skinner; J H Wilmore; D C Rao; C Bouchard Journal: J Appl Physiol (1985) Date: 2001-10
Authors: S C McCloskey; B D Patel; S J Hinchliffe; E D Reid; N J Wareham; D A Lomas Journal: Am J Respir Crit Care Med Date: 2001-10-15 Impact factor: 21.405
Authors: David G Morris; Xiaozhu Huang; Naftali Kaminski; Yanli Wang; Steven D Shapiro; Gregory Dolganov; Adam Glick; Dean Sheppard Journal: Nature Date: 2003-03-13 Impact factor: 49.962
Authors: M Suthanthiran; B Li; J O Song; R Ding; V K Sharma; J E Schwartz; P August Journal: Proc Natl Acad Sci U S A Date: 2000-03-28 Impact factor: 11.205
Authors: A F Tarantal; H Chen; T T Shi; C-H Lu; A B Fang; S Buckley; M Kolb; J Gauldie; D Warburton; W Shi Journal: Eur Respir J Date: 2010-03-29 Impact factor: 16.671
Authors: Chang-Min Lee; Soo Jung Cho; Won-Kyung Cho; Jin Wook Park; Jae-Hyun Lee; Augustine M Choi; Ivan O Rosas; Ming Zheng; Gary Peltz; Chun Geun Lee; Jack A Elias Journal: JCI Insight Date: 2018-09-20
Authors: Michael H Cho; George R Washko; Thomas J Hoffmann; Gerard J Criner; Eric A Hoffman; Fernando J Martinez; Nan Laird; John J Reilly; Edwin K Silverman Journal: Respir Res Date: 2010-03-16
Authors: Tejaswini Kulkarni; Philip O'Reilly; Veena B Antony; Amit Gaggar; Victor J Thannickal Journal: Am J Respir Cell Mol Biol Date: 2016-06 Impact factor: 6.914
Authors: Sunita Sharma; Benjamin A Raby; Gary M Hunninghake; Manuel Soto-Quirós; Lydiana Avila; Amy J Murphy; Jessica Lasky-Su; Barbara J Klanderman; Jody S Sylvia; Scott T Weiss; Juan C Celedón Journal: Am J Respir Crit Care Med Date: 2008-12-18 Impact factor: 21.405